Paediatric oncology
M. Erlacher, H. Cario, L.H. Meyer, A. Schulz, M. Hönig
3 - 6 months
Visiting Residency and Visiting Observership
For visiting residency status - A minimum of intermediate level B2 in German is required (to be approved by the Regional Administrative Council / Supreme Health Authority of the German State of Baden-Wuerttemberg). For visiting observership status - A good level of German language skills is mandatory in order to follow communication between doctors and patients as well as tumor board conferences and recommendations.
Programme description
Within the Paediatric Oncology Programme about 85 children and adolescents per year suffering from a malignant disease are seen and treated at the Paediatric Oncology Centre at the University Children’s Hospital. With this, our Centre is one of the larger Centres for Paediatric Oncology in Germany and treatment of paediatric malignancies is a major focus at our unit. The Paediatric Oncology unit consists of a special ward, a day-care clinic and outpatient department. All kinds of paediatric cancers including solid tumours, leukaemias and lymphomas, central nervous system tumours as well as dysfunctions of haematopoiesis are seen and treated in a team of specialized physicians and nurses closely cooperating with experts from other fields (Paediatric Surgery, Radiology, Radiotherapy, Neurosurgery, Trauma Surgery, Orthopaedics, ENT). Our treatments are carried out under the standardized guidelines laid down by the Society of Paediatric Oncology and Haematology. Furthermore, for very rare malignancies and unfavourable courses of disease we offer a number of novel innovative therapeutic concepts, many of which were developed at our hospital.
In addition, specific treatment of leukaemia, bone marrow failure and in particular immunodeficiency in children and adolescents through bone marrow and stem cell transplantation has been a major focus of our hospital over the past 40 years. Thus, our centre has the longest experience in this type of treatment for children and adolescents in Germany and is one of the largest German centres with a record of more than 1000 transplant patients.
Participants will be involved in diagnosis and treatment of paediatric cancer patients, both in an in- but also outpatients setting, attending tumour boards and conferences, planning and application of anti-neoplastic therapies as well as diagnosis and treatment of corresponding side effects.
